Germany: Proposed regulation increasing transparency at the EFSA threatens IP

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Germany: Proposed regulation increasing transparency at the EFSA threatens IP

On December 11 2018 the European Parliament discussed the proposal for a regulation on the transparency and sustainability of EU risk assessment in the food chain amending, inter alia, Regulation (EC) No 178/2002 [General Food Law].

Public controversy regarding the use of genetically modified organisms and herbicide glyphosate paved the way for an initiative which entailed a legislative proposal by the European Commission (COM (2018)0179). The ensuing regulation will amend the EU's General Food Law Regulation.

On February 11 2019 the European Parliament and the European Council reached a provisional agreement on the EU Commission's Proposal.

At present, the transparency rules of the European Food Safety Association (EFSA) are not as harsh as those of the other agencies – the proposed regulation makes the authorisation procedure harsher than at other agencies. Other agencies (for instance, the European Medicines Agency) publish applications and studies at the time when they publish their opinion.

It is of central interest to the food industry what this proposed regulation requires of companies in terms of when the publication of information and underlying studies in relation to applications are due and which documents must be produced. In accordance with the proposed legislative text, food companies will need to inform the EFSA immediately of the subject matter of studies commissioned.

The revised regulation will entail automatic publication of all studies and information submitted to the EFSA to support the authorisation of a proposed product or ingredient. This data will be uploaded to the EFSA website early in the approval process.

Furthermore, the regulation will establish a database of studies for the EFSA to identify whether all relevant research on a substance is considered in evaluating market applications, and stakeholders and the general public should be involved in consultations and notify the EFSA of any potentially omitted information.

The suggestions presented by the Committee on the Environment, Public Health and Food Safety, for making the proposal more workable, including the requirement that the EFSA should set up a preliminary opinion first and studies and non-confidential information should be published afterwards, were not accepted.

Under the new suggested regulation (see http://europa.eu/rapid/press-release_IP-19-1030_en.htm for updates on the status), the applicant cannot prevent its innovative idea and know-how connected to a new product being presented on the website of the EFSA at the commencement of the application procedure so that any competitor has access to such documents.

Authorisation procedures at the EFSA take up to 59 months – a time period during which competitors in third countries outside the EU will have access to sensitive data while the European application procedure is carried out.

The fact that data and studies will not be published after a consultation period but right at the commencement of the procedure imposes a serious risk of idea and know-how piracy.

EU legislation applicable to the food industry is already considered as very transparent, and the proposal which received the agreement of the council and the commission raises concerns about efficient protection of proprietary information of agri-food companies within the EU.

In this approach, the protection of intellectual property rights comes second to a transparent risk assessment process and it remains unclear how companies are supposed to comply with the requirement to provide a justification for requesting non-publication of their confidential information.

grabow.jpg

Dr Gisela Grabow


Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

The firm says it hopes to capture patent litigation work in Texas by arming itself with experienced trial lawyers with venue expertise
Ken Iijima's arrival continues a trend of ex-Pizzeys practitioners joining RnB IP, whose co-founder says independent ownership and a lucrative compensation model have become attractive in a consolidating market
McDermott Will & Schulte lawyers explore why the UPC is seeing rapid adoption by medtech for fast-moving disputes, while pharma and biotech take a cautious, selective approach over revocation risks
IP firms may be growing more comfortable with external capital, but uncertainty over who could ultimately own the business is complicating the investment pitch
The former Western District of Texas judge addresses perceptions of his courtroom, reveals what comes next as he returns to practice at A&O Shearman and explains why marathon running is ‘cathartic’
International Anti-Counterfeiting Coalition says it has been blocked from hosting its annual event in the city, ending a long tradition of holding the gathering in the days leading up to INTA’s flagship event
The ITC is a powerful tool for litigators, practitioners say, as the threat of an exclusion order on a critical tech component could mean disrupting the entire data centre's operations
Anna Toh plans to expand Rajah & Tann’s soft IP capabilities, leveraging its Southeast Asia network to support clients on cross-border portfolio management and commercial strategy
The Canadian boutique’s new IP lead says he wants to build a tech-enabled IP practice aimed at giving startups senior expertise away from the traditional ‘big law’ set-up
Qantm IP’s acquisition of Henry Goh & Co shows shifting attitudes towards private equity, with firms increasingly viewing external backing as a normal route to expansion rather than a source of concern
Gift this article